IN THE NEWS

THE LATEST NEWS

Servier Doubles Up on Digital Twin Alliance with Aitia

Companies to Focus on Therapeutic Targets Showing Cause and Effect

UCB Enters Drug Discovery Collaboration with Aitia

Research Identifies Potential New Biomarkers of Atherosclerotic Coronary Artery Disease

Becoming Aitia: Why GNS Shifted from AI Provider to Drug Discoverer

New Biomarkers for Atherosclerosis Found Using Digital Twins

The Milken Institute Future of Health Summit – “Is AI Just What the Doctor-or Patient-Ordered?” Panel Discussion

Intelligent Technology Brings Companies To A New Moment Of Truth

Colin Hill Opening Keynote at the Annual Merck Technology Symposium 2022

How AI is helping “drug hunters” succeed – GNS Co-founder, Iya Khalil talk on CNN